In the vast majority of cases, the overall benefits of GLP-1 RAs, including glycemic control, weight loss, and cardiovascular protection, will outweigh this potential risk
If all goes well, it should be available to the publicunder a doctors supervisionin 2027 or 2028
Generally, clinical studies have been known to show that treatment with tirzepatide over a 52-week period led to large amounts of weight loss in comparison to a placebo
Current research in Psychosomatic Medicine regarding the Restrained Eating phenomenon highlights that biological restriction, even if unintentional, leads to increased cortisol and a heightened neural sensitivity to food cues
Some versions, like semaglutide , have a half-life of about a week, which is why they only require once-weekly dosing
It functions similarly by mimicking the naturally occurring hormone GLP-1, helping to regulate appetite and blood sugar levels, which can result in reduced calorie intake and weight loss